Latest stories on STRO
SUTRO BIOPHARMA, INC. (STRO) files 8-K
SEC 8-K50 · neutralgeneral
Sutro Biopharma GAAP EPS of -$2.33 misses by $0.14, revenue of $9.84M misses by $1.2M
Seeking Alpha34 · bearishearnings
Sutro Biopharma Reports Second Quarter 2026 Financial Results and Provides Early Update on STRO-004 Phase 1 Study
Business Insider63 · neutralearnings
Sutro Biopharma initiated with a Buy at Stifel
The Fly61 · neutralanalyst
Stifel initiates Sutro Biopharma stock with buy on ADC platform
Investing.com Analyst Ratings61 · neutralanalyst
Straumann Shares Climb After Lower-Than-Expected Tariffs Boost Outlook
WSJ Business67 · bullishearnings
Straumann Lifts 2026 Profit Outlook On Stronger Margins And China Recovery
TipRanks67 · bullishearnings
SUTRO BIOPHARMA, INC. (STRO) files 8-K
SEC 8-K50 · neutralgeneral